Ventric Health Resources Hub
Your destination for evidence-driven heart failure decision support.
Our resources hub is designed to help you make informed decisions with evidence organized around real-world impact. You’ll discover peer-reviewed research, clinical validation, workflow insights and economic evidence around the questions decision-makers face.
Filter by topic or content type to quickly find the information most relevant to your role, setting and priorities. For additional information about the Vivio System, browse our FAQs.
Study Shows Vivio Enables HF Detection & Triage in Primary Care
A new study in JACC: Advances shows Ventric Health's Vivio System, combined with the KCCQ-12 questionnaire, accurately identified undiagnosed heart failure in primary care patients. The FDA-cleared device non-invasively measures left ventricular filling pressure in five minutes with no hospital visit required. Among 2,040 high-risk patients screened, nearly 25% showed significant HF symptoms, enabling earlier intervention.
Study Compares Vivio to Invasive Implant for Heart Failure Care
Ventric Health is enrolling 500 patients in a study comparing its non-invasive Vivio System to the invasive CardioMEMS implant for monitoring heart failure status. The Vivio System measures left ventricular filling pressure in five minutes, while CardioMEMS requires a surgical implant. If successful, Vivio could eliminate invasive procedures while matching clinical outcomes at lower cost and risk.
Vivio System Named Best Digital/Mobile Health Solution
Ventric Health's Vivio System won Best Digital/Mobile Health Solution at the prestigious Fierce Healthcare Innovation Awards 2023. The mobile, tech-enabled device helps clinicians diagnose heart failure quickly and non-invasively using advanced algorithms to detect elevated left ventricular filling pressure. Vivio was recognized for its effectiveness, technical innovation, and financial impact.
Multicenter Validation: Vivio System for Non-Invasive LVEDP Detection
Findings presented at the 2023 American Heart Association Scientific Symposium highlighted a pivotal study demonstrating validation of a noninvasive brachial cuff-ECG system for estimation of elevated left ventricular end diastolic pressure (LVEDP). The study provides the physician community with evidence that the Vivio® device plays an important role in improving the ability to accurately and non-invasively detect elevated LVEDP.
Ventric Health Receives FDA 510(k) Clearance for Vivio
Ventric Health announced that its medical device, the Vivio System™, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Vivio is a non-invasive medical device developed to quickly deliver the cardiovascular insights value-based care organizations need to reduce costs and improve patient lives.
